HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pedro L Vera Selected Research

Cytokines

12/2010Thrombin induces macrophage migration inhibitory factor release and upregulation in urothelium: a possible contribution to bladder inflammation.
11/2010Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
4/2010Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.
6/2009Intraluminal blockade of cell-surface CD74 and glucose regulated protein 78 prevents substance P-induced bladder inflammatory changes in the rat.
1/2009Substance P increases cell-surface expression of CD74 (receptor for macrophage migration inhibitory factor): in vivo biotinylation of urothelial cell-surface proteins.
5/2008Upregulation of macrophage migration inhibitory factor (MIF) and CD74, receptor for MIF, in rat bladder during persistent cyclophosphamide-induced inflammation.
1/2008Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association.
12/2006Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.
7/2005Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer.
2/2005Substance P induced changes in CD74 and CD44 in the rat bladder.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pedro L Vera Research Topics

Disease

21Inflammation (Inflammations)
03/2019 - 08/2003
9Pain (Aches)
01/2022 - 01/2015
7Cystitis
03/2019 - 08/2003
7Hypersensitivity (Allergy)
01/2019 - 04/2004
6Neoplasms (Cancer)
10/2011 - 07/2004
4Hyperalgesia
01/2022 - 10/2004
4Edema (Dropsy)
05/2017 - 01/2004
3Prostatic Neoplasms (Prostate Cancer)
05/2011 - 07/2005
2Neuralgia (Stump Neuralgia)
03/2019 - 01/2019
2Interstitial Cystitis (Interstitial Cystitis, Chronic)
03/2019 - 01/2018
2Urinary Bladder Neoplasms (Bladder Cancer)
04/2010 - 07/2004
2Adenocarcinoma
07/2005 - 07/2004
2Neurogenic Inflammation
10/2004 - 04/2004
1Skin Neoplasms (Skin Cancer)
01/2019
1Carcinogenesis
04/2010
1Body Weight (Weight, Body)
07/2008
1Urinary Tract Infections (Urinary Tract Infection)
04/2006
1Abnormal Reflex (Hyperreflexia)
12/2004
1Neurogenic Urinary Bladder (Bladder, Neurogenic)
04/2004
1Ganglion Cysts (Ganglion)
01/2004

Drug/Important Bio-Agent (IBA)

30Macrophage Migration-Inhibitory FactorsIBA
01/2022 - 08/2003
14CytokinesIBA
12/2010 - 08/2003
7Proteins (Proteins, Gene)FDA Link
01/2015 - 08/2003
6HMGB1 Protein (HMG1)IBA
01/2022 - 01/2016
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2019 - 01/2008
5Substance PIBA
06/2009 - 04/2004
4protease-activated receptor 4IBA
01/2019 - 01/2016
4Messenger RNA (mRNA)IBA
11/2010 - 08/2003
3macrophage migration inhibitory factor receptorIBA
01/2021 - 05/2008
3Peptides (Polypeptides)IBA
01/2019 - 01/2016
3Glycyrrhizic Acid (Glycyrrhizin)IBA
01/2019 - 01/2016
3Peptide Hydrolases (Proteases)FDA Link
10/2018 - 09/2006
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2004 - 08/2003
2DisulfidesIBA
12/2017 - 05/2017
2ThrombinFDA Link
12/2010 - 04/2010
2Nerve Growth Factor (NGF)IBA
11/2010 - 10/2004
2LigandsIBA
01/2008 - 12/2006
2alpha 1-inhibitor 3IBA
09/2006 - 07/2005
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1Butylated Hydroxyanisole (BHA)IBA
01/2022
1Monoclonal AntibodiesIBA
01/2019
1Analgesics (Analgesic Drugs)IBA
01/2019
1Phosphodiesterase 5 InhibitorsIBA
01/2019
1MIF098IBA
10/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Proteinase-Activated ReceptorsIBA
12/2017
1Sulfhydryl Compounds (Thiols)IBA
05/2017
1ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA
05/2017
1Toll-Like Receptor 4IBA
05/2017
1FPS-ZM1IBA
05/2017
1Carrier Proteins (Binding Protein)IBA
01/2016
1ChromatinIBA
01/2016
1plerixaforFDA Link
01/2015
1Atrial Natriuretic Factor (ANF)IBA
05/2011
1Hormones (Hormone)IBA
05/2011
1atrial natriuretic factor receptor AIBA
05/2011
1Natriuretic PeptidesIBA
05/2011
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
11/2010
1Biological ProductsIBA
11/2010
1Endoplasmic Reticulum Chaperone BiPIBA
06/2009
1Lidocaine (Xylocaine)FDA LinkGeneric
07/2008
1Phentolamine (Z-Max)FDA LinkGeneric
07/2008
1AtropineFDA LinkGeneric
07/2008
1Propranolol (Inderal)FDA LinkGeneric
07/2008
1Neurotransmitter Agents (Neurotransmitter)IBA
07/2008
1Hexamethonium (Hexamethonium Bromide)IBA
07/2008
1Chemokine ReceptorsIBA
01/2008
1AndrogensIBA
12/2006
1Formaldehyde (Formol)FDA Link
12/2004
1Phenobarbital (Luminal)FDA Link
10/2004
1NeuropeptidesIBA
04/2004
1EndotoxinsIBA
01/2004

Therapy/Procedure

3Intravesical Administration
01/2019 - 05/2017
1Aftercare (After-Treatment)
01/2015
1Therapeutics
12/2006